BCR-ABL-IN-11
Product Specifications
CAS Number
2362-25-6
Target
Bcr-Abl
Related Pathways
Cytoskeletal Signaling, Angiogenesis, Tyrosine Kinase/Adaptors
Bioactivity
BCR-ABL-IN-11 (Compound 2) is an inhibitor of BCR-ABL, exhibiting anticancer activity against chronic myelogenous leukemia (CML) with an IC50 value of 129.61 μM in K562 cells.
Smiles
O=C(NC1=CC=CC(=C1)NC(=O)C2=CC=C(N)C=C2)C3=CC=C(N)C=C3
Molecular Formula
C20H18N4O2
Molecular Weight
346.383
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
134592 100 µg
Tenascin-X (TNX, TN-X, TNXB, Hexabrachion-like Protein, HXBL, TNXB1, TNXB2, XB)
Sign In for Pricing
View Details D3931-62D-HRP 200 µL
Dnmt2, NT (Putative DNA Cytosine Methyltransferase DNMT2, DNA Methyltransferase Homolog MmuIIP, DNA MTase Homolog MmuIIP, M.MmuIIP, Met-2, tRNA (Cytosine-5-) -methyltransferase, DNA (Cytosine-5) -methyltransferase-like Protein 2, DNA Methyltransferase Homolog MmuIIP, Trdmt1, Met2) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details 